Skip to main content
FinSpry Logo
FinSpry
NTLA logo
NTLA
(NASDAQ)
Intellia Therapeutics, Inc.
$12.74-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Intellia Therapeutics, Inc. (NTLA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Intellia Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(10 total ratings in last 90 days)
Medium Confidence4.0:1 Buy/Sell

Average Price Target

$23.80
↑ 86.81% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NTLA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
Wedbush
HoldMaintains
$12.00 → $17.00
Whitney Ijem
Canaccord Genuity
BuyMaintains
$49.00
Alec Stranahan
BofA Securities
HoldMaintains
$19.00
Unknown Analyst
Wedbush
HoldMaintains
$12.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$25.00
Myles Minter
William Blair
BuyReiterates
-
Joseph Thome
TD Cowen
BuyMaintains
-
Salveen Richter
Goldman Sachs
SellMaintains
$9.00
Joseph Thome
TD Cowen
BuyMaintains
-
Salveen Richter
Goldman Sachs
SellMaintains
$9.00

Frequently Asked Questions

What is the analyst consensus rating for NTLA?

The analyst consensus rating for NTLA is "Buy" based on 7 analyst recommendations.

What is the average price target for NTLA?

The average 12-month price target for NTLA is $23.80, representing an upside of 86.8% from the current price of $12.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.